We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENB icon
3801
CALL
Enbridge
ENB
$113B
$12K ﹤0.01%
43,200
+400
+0.9% +$16.9K
GSK icon
3802
CALL
GSK
GSK
$102B
$12K ﹤0.01%
79,500
-740
-0.9% -$28K
ORIO
3803
Orion Digital Corp
ORIO
$18.7M
$12K ﹤0.01%
4,350
-267
-6% -$842
T icon
3804
CALL
AT&T
T
$168B
$12K ﹤0.01%
38,000
-12,600
-25% -$229K
TMDI
3805
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$12K ﹤0.01%
27,746
-5,000
-15% -$2.59K
ADAP
3806
DELISTED
Adaptimmune Therapeutics
ADAP
$11K ﹤0.01%
10,573
CMCSA icon
3807
CALL
Comcast
CMCSA
$91B
$11K ﹤0.01%
76,400
+100
+0.1% +$3.74K
JOB icon
3808
GEE Group
JOB
$21.2M
$11K ﹤0.01%
18,000
-10,000
-36% -$6.2K
MCHP icon
3809
CALL
Microchip Technology
MCHP
$44B
$11K ﹤0.01%
+13,200
New +$867K
NOG icon
3810
CALL
Northern Oil and Gas
NOG
$2.58B
$11K ﹤0.01%
28,200
-300
-1% -$8.47K
SNV
3811
CALL
DELISTED
Synovus
SNV
$11K ﹤0.01%
44,100
SYBX
3812
DELISTED
Synlogic
SYBX
$11K ﹤0.01%
800
TMQ
3813
Trilogy Metals
TMQ
$679M
$11K ﹤0.01%
17,990
ARVL
3814
DELISTED
Arrival Ordinary Shares
ARVL
$11K ﹤0.01%
277
-160
-37% -$10.5K
NCNO icon
3815
CALL
nCino
NCNO
$2.1B
$10K ﹤0.01%
+12,900
New +$435K
APA icon
3816
CALL
APA Corp
APA
$14.2B
$9K ﹤0.01%
34,200
-21,500
-39% -$769K
AVT icon
3817
CALL
Avnet
AVT
$7.87B
$9K ﹤0.01%
12,500
-500
-4% -$21.5K
DLR icon
3818
CALL
Digital Realty Trust
DLR
$70.6B
$9K ﹤0.01%
30,800
-16,200
-34% -$1.99M
FRSX
3819
Foresight Autonomous Holdings
FRSX
$4.2M
$9K ﹤0.01%
139
LITS
3820
Lite Strategy Inc
LITS
$30.7M
$9K ﹤0.01%
1,118
+247
+28% +$2.55K
PAVM icon
3821
PAVmed
PAVM
$33.7M
$9K ﹤0.01%
24
PLTR icon
3822
CALL
Palantir
PLTR
$420B
$9K ﹤0.01%
+24,000
New +$213K
MTEM
3823
DELISTED
Molecular Templates, Inc.
MTEM
$9K ﹤0.01%
770
RMO
3824
DELISTED
Romeo Power, Inc.
RMO
$9K ﹤0.01%
23,684
-15,500
-40% -$9.33K
DOW icon
3825
CALL
Dow Inc
DOW
$22.6B
$8K ﹤0.01%
53,800
+28,900
+116% +$1.47M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.